Evaxion A/S Files October 2025 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Oct 8, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Oct 8, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Evaxion A/S filed its October 6-K, standard procedure for foreign private issuers.
AI Summary
Evaxion A/S, a biotechnology company, filed a Form 6-K on October 8, 2025, reporting for the month of October 2025. The company is incorporated in G7 and has its principal executive office in Hoersholm, Denmark. Evaxion A/S previously operated under the name Evaxion Biotech A/S before a name change on October 14, 2020.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Evaxion A/S's ongoing operations and corporate status as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would typically increase risk.
Key Numbers
- 001-39950 — SEC File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- Evaxion A/S (company) — Registrant
- Evaxion Biotech A/S (company) — Former company name
- 001-39950 (dollar_amount) — SEC File Number
- October 8, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was Evaxion A/S previously known as Evaxion Biotech A/S?
Evaxion A/S was formerly known as Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Where is Evaxion A/S's principal executive office located?
Evaxion A/S's principal executive office is located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Does Evaxion A/S file annual reports under Form 20-F?
Yes, Evaxion A/S indicates by check mark that it files or will file annual reports under cover of Form 20-F.
What is the SIC code for Evaxion A/S?
The Standard Industrial Classification (SIC) code for Evaxion A/S is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 10.7 · Accepted 2025-10-08 08:05:44
Filing Documents
- f6k_100825.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-006342.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evaxion A/S (Registrant) Date: October 8, 2025 By: /s/ Birgitte Rn Birgitte Rn Interim Chief Executive Officer